Peer Review History

Original SubmissionMay 8, 2025
Decision Letter - Alberto Molina Pérez, Editor

Dear Dr. Merz,

Thank you for submitting your manuscript to PLOS ONE. Before it is accepted for publication, we invite you to submit a revised version of the manuscript that addresses the suggestions for improvement from the two reviewers.

Please submit your revised manuscript by Jul 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Alberto Molina Pérez, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

5. Thank you for stating the following financial disclosure:

This work was funded by the Dutch Ministry of Health, Welfare, and Sport (Project Grants), case number 90001539.

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

7. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set.

Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Reviewer Comments

Dr Britzer Paul Vincent

Firstly, I would like to thank the editor and authors for the opportunity to review this manuscript titled “Exploring the perceptions of living donation among potential Moroccan donors in the Netherlands.” This is a highly valuable and timely piece of work, and I am pleased to note that it was commissioned by the Dutch Ministry of Health, Welfare, and Sport. The methodological rigour demonstrated reflects the considerable effort invested in this study. The findings related to religious legitimacy particularly resonate with the findings of our recently published systematic review, “Barriers and facilitators of deceased organ donation among Muslims living globally: An integrative systematic review.”

I offer the following minor but important comments for consideration prior to acceptance for publication:

1. Terminology Consistency: Research involving ethnically diverse populations is vital. However, for the research to be both accurate and meaningful, the terminology used to describe these populations must be consistent and clearly defined. In this manuscript, the study population is referred to variously as ‘Moroccan donors in the Netherlands’ and ‘Moroccan-Dutch population’. Using different terms to refer to the same population may cause confusion. It is recommended that one term is used consistently throughout the manuscript. If these terms are intended to denote different groups, please provide a clear rationale and definition. For instance:

o Moroccan-Dutch could refer to individuals of Moroccan origin who hold Dutch citizenship or reside in the Netherlands and identify as having both Dutch and Moroccan cultural affiliations.

o Moroccans living in the Netherlands might encompass a broader term encompassing all Moroccans in the Netherlands, including those who may not be Dutch citizens or who do not identify as Moroccan-Dutch.

This point is particularly important, as inconsistencies in ethnic classification have been shown to present limitations in systematic reviews and scoping studies (see: [Review 1: Barriers towards deceased organ donation among Indians living globally]; [Review 2: Barriers to conversations about deceased organ donation among adults living in the UK]).

2. Line 75–76: The statement “A considerable proportion of this group will eventually need human tissue transfusion or transplantation” should be supported by a relevant reference. If available, please provide an estimate of the prevalence of end-stage organ failure among this population to substantiate the claim.

3. Line 122: Please clarify how “Dutch individuals of Moroccan descent” were identified. Were participants asked to provide any documentation to confirm their ethnic background or nationality? If not, kindly state that participants self-identified as Moroccan-Dutch/Dutch individuals of Moroccan descent/Moroccans living in the Netherlands (the term confusion aligns with the earlier point regarding the need for consistent and well-defined terminology.)

4. Line 127: About recruitment, when mentioning “diversity in attitudes toward the topic”, please explain how this variation was assessed or identified during participant selection.

5. Line 129–130: Please specify the language(s) in which the survey and focus group discussions were conducted. Also, indicate who facilitated the focus groups and comment on their fluency or proficiency in the relevant language(s).

6. Line 151–152: Please provide a rationale for conducting mixed-gender focus groups. Given the sensitivity of the topic and its cultural and religious dimensions, it is common practice to conduct gender-segregated groups to promote openness and to mitigate power or speech dynamics that may inhibit discussion.

7. Line 161–162: Again, kindly specify the language used for both the survey and focus groups. If translation was required, please describe how it was conducted and verified.

8. Line 178–179: This line suggests that English was not the language used for data collection. It is essential to state earlier in the methods section the language used, the facilitator’s language proficiency, and the process followed for translation and verification.

9. Reflexivity Section: It would strengthen the methodological transparency of the study to include information regarding the researchers’ language proficiency and their cultural competence or awareness in relation to the study population.

10. Line 224–225: Please revise the sentence for clarity: “Tables 1 and 2 present the characteristics of survey respondents and focus group participants, respectively.”

11. Table 1: Please define what is meant by “partial Moroccan”. Does this refer to mixed heritage or other criteria?

12. Table 1: The question on stem cell donation appears to ask about registration, whereas the questions on blood and organ donation refer to actual donation history. Please explain this discrepancy or justify this variation in framing.

13. Table 1: The response to the question “Have you ever donated an organ or part of an organ?” shows n = 100 for No, yet the percentage is listed as 0%. Kindly correct this inconsistency.

14. Table 2 – Education Level: Please clarify the meaning of “University of applied sciences”. Do you mean vocational tertiary education? Also, consider aligning educational categories with international equivalents such as Bachelor’s, Master’s, and PhD degrees for clarity.

15. Line 239: The term “frequency of occurrence” may imply quantitative enumeration. Consider rephrasing to simply state “…and their occurrence across different tissue types.”

16. Recommendations Table: As stated in line 92, one of the fund’s aims was to “inform and develop evidence-based campaigns.” In light of this, it would be beneficial to conclude the manuscript with a table of actionable recommendations, derived from the ten identified themes. This would be of practical value for policymakers and campaign developers working with this population in the Netherlands.

Reviewer #2: This is a well written clearly structured and highly relevant manuscript that effectively explores the perceptions of living donation among potential Moroccan donors in the Netherlands. The message is portrayed clearly and this study offers original and valuable insights pertinent to the clime. The article is relevant to this specific population group studied.

I commend the authors for their adherence to the COREQ guidelines, which significantly enhances the transparency and rigor. The methodology section is detailed and explicit, clearly providing a road map of the research process. The data presentation is clear and accessible making the findings easy to interpret.

Comments for Consideration

1. Participant codes in Table 2 - please can you clarify if these codes depict any specific meaning specifically what do the letters after the numbers signify? (e.g., " V1-S", " V3-M") it is OK if there is no significance.

2. Table 3 caption- write out the caption for types of donation within the table as this will ensure that anyone viewing the table as a standalone can easily understand the categories of donations presented without needing to refer back to the main text.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Britzer Paul Vincent

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

We addressed all editor and reviewer comments in a separate file, attached as 'Response to reviewers'. As we give answers to every comment in a table format, we cannot paste the text here, as it would ruin its readibility.

Decision Letter - Alberto Molina Pérez, Editor

Exploring the perceptions of living donation among potential Moroccan donors in

the Netherlands

PONE-D-25-23161R1

Dear Dr. Merz,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Alberto Molina Pérez, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Congratulations for this well designed and well conducted study! Also, I wish to thank the two reviewers for their thourough review and constructive comments.

Reviewers' comments:

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .